Swayze Eric
SEC CIK 1791058 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | Off. Level 14 | 21.8K | — | $11.15M | 51 | 2022-01-18 | 2026-06-25 |
Most active insiders at IONS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Monia Brett P | CEO, Dir | — | $30.35M |
| 2 | HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| 3 | BENNETT C FRANK | EVP, CSO | — | $16.71M |
| 4 | Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| 5 | O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| 6 | Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| 7 | Swayze Eric | EVP Research | — | $7.51M |
| 8 | LOSCALZO JOSEPH | Dir | — | $7.09M |
| 9 | KLEIN JOSEPH III | Dir | — | $6.00M |
| 10 | WENDER JOSEPH H | Dir | — | $5.44M |
Transactions 51
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-26 19:09 | 2026-06-25 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $79.18 | -10.6K | 21.8K | -33% | -$839.5K |
| 2026-03-03 | 2026-02-27 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | J - Other | $48.87 | +256 | 32.4K | +0.8% | +$12.5K | |
| M | 2026-02-13 | 2026-02-13 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $81.76 | -15.6K | 38.3K | -29% | -$1.28M |
| 2026-02-02 | 2026-01-29 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | A - Grant | $0.00 | +12.0K | 53.9K | +29% | $0 | |
| 2026-02-02 | 2026-01-30 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $82.93 | -6,179 | 47.7K | -11% | -$512.4K | |
| D | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +21.4K | 51.8K | +70% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $75.34 | -9,884 | 41.9K | -19% | -$744.7K |
| DI | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +111 | 367 | +43% | $0 |
| DI | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $75.97 | -49 | 318 | -13% | -$3,723 |
| DM | 2026-01-06 | 2026-01-02 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $60.89 | +23.5K | 48.8K | +93% | +$1.43M |
| DM | 2026-01-06 | 2026-01-02 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $79.12 | -23.5K | 30.5K | -44% | -$1.86M |
| DI | 2025-10-16 | 2025-10-15 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +125 | 309 | +68% | $0 |
| DI | 2025-10-16 | 2025-10-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $73.62 | -53 | 256 | -17% | -$3,902 |
| 2025-10-08 | 2025-10-06 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $69.02 | -6,849 | 30.5K | -18% | -$472.7K | |
| DM | 2025-10-02 | 2025-10-01+ | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $66.16 | -27.1K | 37.3K | -42% | -$1.79M |
| DM | 2025-10-02 | 2025-10-01+ | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $53.77 | +27.1K | 51.4K | +111% | +$1.46M |
| M | 2025-09-04 | 2025-09-02 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $49.67 | -11.1K | 38.4K | -22% | -$552.9K |
| 2025-03-04 | 2025-02-28 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | J - Other | $28.21 | +415 | 48.4K | +0.9% | +$11.7K | |
| 2025-02-03 | 2025-01-31 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $32.31 | -1,367 | 48.0K | -3% | -$44.2K | |
| 2025-02-03 | 2025-01-30 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | A - Grant | $0.00 | +3,714 | 49.4K | +8% | $0 | |
| DI | 2025-01-17 | 2025-01-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $32.70 | -22 | 184 | -11% | -$719.40 |
| D | 2025-01-17 | 2025-01-15 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +19.1K | 52.8K | +57% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $32.84 | -7,154 | 45.7K | -14% | -$234.9K |
| DI | 2025-01-17 | 2025-01-15 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +49 | 206 | +31% | $0 |
| 2024-11-14 | 2024-11-12 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $37.92 | -1,194 | 33.7K | -3% | -$45.3K | |
| DI | 2024-10-17 | 2024-10-15 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +125 | 210 | +147% | $0 |
| DI | 2024-10-17 | 2024-10-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $38.31 | -53 | 157 | -25% | -$2,030 |
| A | 2024-09-04 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $49.56 | -1,940 | 34.3K | -5% | -$96.1K |
| 2024-09-04 | 2024-08-30 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | J - Other | $38.64 | +11 | 34.9K | +0.0% | +$425.04 | |
| 2024-03-04 | 2024-02-29 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | Off. Level 14 | J - Other | $34.43 | +605 | 34.9K | +2% | +$20.8K | |
| 2024-02-02 | 2024-02-01 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | A - Grant | $0.00 | +3,715 | 36.2K | +11% | $0 | |
| M | 2024-02-02 | 2024-01-31+ | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $51.63 | -12.7K | 32.5K | -28% | -$654.7K |
| DI | 2024-01-18 | 2024-01-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +21 | 94 | +29% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $50.42 | -6,296 | 43.3K | -13% | -$317.4K |
| D | 2024-01-18 | 2024-01-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +17.1K | 49.6K | +52% | $0 |
| DI | 2024-01-18 | 2024-01-17 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $50.42 | -9 | 85 | -10% | -$453.78 |
| D | 2024-01-02 | 2023-12-28 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $47.34 | +27.1K | 59.6K | +83% | +$1.28M |
| D | 2024-01-02 | 2023-12-28 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $50.19 | -27.1K | 32.5K | -45% | -$1.36M |
| DI | 2023-10-18 | 2023-10-17 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $47.95 | -52 | 73 | -42% | -$2,493 |
| DI | 2023-10-18 | 2023-10-16 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +125 | 125 | New | $0 |
| 2023-03-02 | 2023-02-28 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | J - Other | $30.52 | +575 | 32.5K | +2% | +$17.5K | |
| 2023-02-07 | 2023-02-03 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | A - Grant | $0.00 | +3,715 | 33.8K | +12% | $0 | |
| 2023-02-07 | 2023-02-06 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $40.79 | -1,815 | 31.9K | -5% | -$74.0K | |
| D | 2023-01-19 | 2023-01-18 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale+OE | $39.74 | -5,631 | 30.0K | -16% | -$223.8K |
| D | 2023-01-19 | 2023-01-17 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +15.8K | 35.7K | +79% | $0 |
| 2022-09-12 | 2022-09-08 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $44.55 | -460 | 19.9K | -2% | -$20.5K | |
| 2022-08-09 | 2022-08-05 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $45.20 | -1 | 20.4K | -0.0% | -$45.20 | |
| 2022-04-25 | 2022-04-21 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | S - Sale | $44.15 | -378 | 20.4K | -2% | -$16.7K | |
| 2022-03-02 | 2022-02-28 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | J - Other | $28.37 | +621 | 20.7K | +3% | +$17.6K | |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | F - Tax | $30.12 | -4,994 | 20.1K | -20% | -$150.4K |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | Swayze Eric | EVP Research | M - OptEx | $0.00 | +13.8K | 25.1K | +122% | $0 |
Purchase Sale Sale after option exercise All abbreviations